nav_top

Username:
Password:

Remember Me
Forgot Password

Benefits of Membership
Search By Keyword Or Search By

NCPA Approved Respiratory Care Certificate Program

Please review the following information and then login to the activity.

Release Date: December 18, 2007
Expiration Date: December 18, 2010

NCPA is a leader in educating community pharmacists on how to develop patient care niches focused on disease management and wellness. This program will provide participants with 6 modules and a pharmacist tool kit totaling 15 ACPE continuing education contact hours (1.5 CEUs) in pharmacy education. For a complete listing of NCPA educational programs, refer to www.ncpanet.org.

Program Overview:

Community pharmacists are in an ideal position to identify patients with respiratory diseases or help manage patients who have already been diagnosed with Asthma or Chronic Obstructive Pulmonary Disease (COPD). This Respiratory Care Certificate Program provides practical information community pharmacists need on screening and managing patients with respiratory conditions through reviewing patient prescription records, screening, and counseling patients on medications, lifestyle issues and device usage.

20.5 million people in the U.S. have been diagnosed with Asthma with 9 million of those diagnoses in children under 18 years of age. Asthma results in 12.7 million physician office visits and 500,000 hospitalizations as well as 2 million Asthma related emergency room visits yearly. The cost to society is 16.1 billion dollars. COPD is the 4th leading cause of death in the U.S. and although estimates are that 30 million people have COPD, only 16 million of those have been diagnosed and are undergoing treatment. 5% of all physician visits in the U.S. are related to COPD and 15% of all hospitalizations are a result of COPD. The direct and indirect costs to society of COPD are $37.2 billion.

A patient care niche focused on respiratory care can be professionally rewarding for pharmacists and add significantly to the quality of life of patients. Learn the ins and outs of establishing a successful niche focused on respiratory care.

Target Audience: Pharmacists

Professional Competencies:

At the conclusion of this program, participants should be able to:

  • Define and describe the pathophysiology and prevalance of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
  • Explain primary goals for management of Asthma
  • Develop individualized trigger avoidance plans for patients
  • Discuss the role and value of the various pharmacotherapeutic choices to treat Asthma and COPD, including mechanisms of action, dosing, administration, adverse effects and precautions
  • Discuss considerations for the management of asthma in special populations
  • Describe specific services pharmacists can provide to patients with asthma or COPD
  • Review Medicare Medication Therapy Management and the implications for respiratory care reimbursement
  • Develop a business plan for a respiratory management program

Accreditation:

The National Community Pharmacists Association (NCPA) is approved by the Accreditation Council for Pharmacy Education (ACPE) as an approved provider of general pharmacy education and certificate programs. This online home study program consists of 15 contact hours (1.5 CEUs) of continuing education (CE) credit. This program is no longer valid after December 18, 2010. This education program is a publication of NCPA.

Program Title ACPE
Universal Program Number
Module 1: Pathophysiology and Clinical Features of Asthma 207-000-07-154-H01-P
Module 2: Treatment of Asthma 207-000-07-155-H01-P
Module 3: Medication Administration and Patient Monitoring 207-000-07-156-H01-P
Module 4: Special Populations 207-000-07-157-H01-P
Module 5: Chronic Obstructive Pulmonary Disease (COPD) 207-000-07-158-H01-P
Module 6: Pharmacy Based Respiratory Therapy Services 207-000-07-159-H01-P

Acknowledgements:

Faculty

Geneva Clark Briggs, Pharm.D., BCPS

Scott K. Stolte, Pharm.D.

Editorial Staff

Colleen Brennan R.Ph.
Barbara Hayward
Stacey M. Swartz, Pharm. D.

Instructions:

To receive continuing education credit you must review the full content of each module and successfully complete the post-test following each module. This program contains 6 modules and 6 post-tests. You must receive a grade of 70% or higher to pass each post-test. Your statement of credit will be issued electronically and immediately upon successful completion of each post-test and submission of the evaluation. A Certificate of Achievement will also be issued electronically immediately upon successful completion of all post-tests.

Activity Fee: There is no fee associated with this activity.

Commercial Support Statement: This professional education program is supported through an educational program grant from Merck & Co., Inc.

Disclosure Declaration:

It is the policy of NCPA® for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest(s) that provide products or services that may be relevant to the content of this continuing medical educational activity.

NCPA has no relevant financial relationship with any commercial interests related directly or indirectly to the content of this educational activity.

Faculty Disclosure:

Geneva Briggs discloses that she has no relevant financial relationship with the program sponsor.

Scott Stolte discloses that he has no relevant financial relationship with the program sponsor.

Software Requirements:

PC
Windows 2000 or above
Flash Player Plugin 7.0.1 Check my Flash Version
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader

*Required to view Printable PDF Version

MAC
Mac OS 10.2.8
Flash Player Plugin 7.0.1 Check my Flash Version
Safari
*Adobe Acrobat Reader

*Required to view Printable PDF Version